Sanofi

Sanofi-aventis

Sanofi-synthelabo

Other

Institut National De La Sante Et De La Recherche Medicale

Elf Sanofi

Sanofi Sa

C M Industries

Societe Anonyme Sanofi

Societe Anonyme Dite : Sanofi

Jean Wagnon

Dino Nisato

Bernard Tonnerre

Richard Roux

Claudine Serradeil-Legal

Claudine Serradeil-Le Gal

Alain Di Malta

Georges Garcia

Gerard Valette

Loic Foulon

Claude Plouzane

Paul De Cointet

Henri Demarne

Victor Dos Santos

Jean-Pierre Gagnol

Bruno Schoentjes

Jean-Marc Herbert

Patrick Gautier

Françoise Bono

Michaël Bosch

Catherine Cazaubon

Marie-Sophie Amiel

Georges Callet

Alain Aulombard

Antoine Pradines

Remy Guegan

Colette Lacour

Alain Roccon

David Marchionni

The present invention is directed to compounds of formula (I): described as novel indolizine derivatives and to a method for their preparation along with pharmaceutical compositions thereof whose substituents are as described in the specification.

Indolizine derivatives, method for preparing same, and therapeutic compositions comprising same

The invention relates to 4-[(arylmethyl)aminomethyl]piperidine derivatives of general formula (I) in the form of a base or an addition salt with an acid, and also in the form of a hydrate or solvate, and their preparation process and therapeutic application.

4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application

The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I)  

Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof

The invention relates to compounds of formula: and to solvates and/or hydrates thereof, with affinity for and selectivity towards the Vreceptors or both the Vand Vreceptors of arginine-vasopressin. The invention also relates to a process for preparing them, to the intermediate compounds of formula (II) which are useful for preparing them, to pharmaceutical compositions containing them and to their use for preparing medicinal products.

1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them

The invention relates to substituted (4-phenylpiperazin-1-yl)acylpiperidine derivatives of formula (I) in the form of a base or an addition salt with an acid, and also in the form of a hydrate or solvate, and their preparation process and therapeutic application.

(4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics

The invention relates to compounds of formula: as well as the possible salts thereof with mineral or organic acids, and the solvates and/or hydrates thereof, which have affinity for and selectivity towards the Vreceptors or towards both the Vand Vreceptors of arginine-vasopressin. The invention also relates to the process for preparing them, to the intermediate compounds of formula (II) that are useful for preparing them, to pharmaceutical compositions containing them and to their use for the preparation of medicinal products.

[object Object]

The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I) in which:  Preparation process and therapeutic application.

The invention relates to acyloxypyrrolidine derivatives of general formula (I): in which:

Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic

1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them

The invention relates to compounds of formula:  and also to the salts thereof with mineral or organic acids, and the solvates and/or hydrates thereof, with affinity for and selectivity towards the arginine-vasopressin Vreceptors and/or for the ocytocin receptors and, furthermore, for certain compounds, affinity for the Vreceptors. The invention also relates to the process for preparing them, to the intermediate compounds of formula (IV) that are useful for preparing them, to pharmaceutical compositions containing them and to their use for preparing medicinal products.

Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use

The invention relates to compounds of formula:and to solvates and/or hydrates thereof, with affinity for and selectivity towards the Vreceptors or both the Vand Vreceptors of arginine-vasopressin. The invention also relates to a process for preparing them, to the intermediate compounds of formula (II) which are useful for preparing them, to pharmaceutical compositions containing them and to their use for preparing medicinal products.

1,3-dihydro-2H-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them

1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors

1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them

1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same

The invention relates to 1-Benzenesulfonyl-1,3-dihydroindol-2-one derivatives of the formula ##STR1## and their salts, where appropriate, to their preparation and to pharmaceutical compositions in which they are present. These compounds have an affinity for the vasopressin and/or ocytocin receptors.

1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their

Growing community of inventors

Montpellier, France

Jean Wagnon